# Bexarotene

NDC: 43975-315
Generic name: Bexarotene
Labeler / Manufacturer: ANI Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20180510

FDA application: ANDA209861

## Active ingredients

- BEXAROTENE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43975-315"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43975-315
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e713c60d-f623-4260-b0ca-db07e1365fd2